Across TCGA pan-cancer cohorts, MTMR7 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated MTMR7 data layer compared with 7 for mutation status and 1 for mass-spec protein.
The strongest signal is observed in kidney chromophobe (KICH), where higher MTMR7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTMR7 expression acts as an unfavorable survival marker, although some lineages such as LGG and PAAD show a favorable association.
KICH, STAD, and LGG are the cancer types where MTMR7 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.